TOKYO, May 27, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO22), which is taking place virtually and in-person in Chicago from June 3 to 7. Notable […]
Medical workers from Hubei check information at a makeshift hospital in Pudong New Area, Shanghai. (ZHU XINGXIN / CHINA DAILY) BEIJING – The Chinese mainland on Sunday reported 174 locally-transmitted confirmed COVID-19 cases, of which 83 were in Beijing, 55 in Shanghai and 32 in Tianjin, the National Health Commission said Monday. Following the recovery […]
Fatigue, insomnia and muscle weakness plague survivors, research report shows COVID-19 patients leave the National Exhibition and Convention Center (NECC), the largest makeshift hospital, in East China's Shanghai, April 14, 2022. (PHOTO / XINHUA) Around half of recovered COVID-19 patients report at least one symptom two years after their infection with the disease, a study […]
Medical workers take swab samples from residents for nucleic acid test at a COVID-19 testing site in Kangcheng community, East China's Shanghai, March 19, 2022. (XINHUA) BEIJING – The Chinese mainland Sunday reported 846 locally-transmitted confirmed COVID-19 cases, of which 727 were in Shanghai, according to the National Health Commission's report Monday. Apart from Shanghai, […]
Medical staff work at the intensive care unit (ICU) of the southern branch of Renji Hospital in Shanghai, East China, April 24, 2022. (PHOTO / XINHUA) Health authorities stressed on Thursday that hospitals must not refuse patients and should ensure patients in need get timely care during the upcoming May Day holiday since China's COVID-19 […]
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, will host an R&D call on Tuesday, May 03, 2022 at 9:00 AM Eastern Time. Panbela’s management team will be joined by leading experts for a […]
A community worker helps local residents register information before the nucleic acid test in Changning district of east China's Shanghai, April 1, 2022. (PHOTO / XINHUA) BEIJING – The Chinese mainland Friday reported 3,867 locally-transmitted confirmed COVID-19 cases, of which 3,590 were in Shanghai, according to the report of the National Health Commission Saturday. A […]
TOKYO, Mar 28, 2022 – (JCN Newswire via SEAPRWire.com) – Gilead Sciences K.K., Eisai Co., Ltd. and EA Pharma Co., Ltd. announced that Gilead acquired an approval of additional indication of Jyseleca (Generic name: Filgotinib, “Jyseleca”), Janus Kinase (JAK) inhibitor, for the treatment of patients with active moderate-to-severe ulcerative colitis in Japan. In September 2020, […]
Tokyo and Salt Lake City, Indianapolis, Mar 25, 2022 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One […]
Residents take photos of cherry blossoms in Shanghai, on March 23, 2022. (ZHOU YAO / CHINA DAILY) Shanghai has no plans to impose a citywide lockdown despite the spike in new COVID-19 infections, the Shanghai health authority reiterated on Wednesday in response to rumors circulating on social media on Tuesday night. The city reported 981 […]
HONG KONG, Mar 14, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that, the Investigational […]
TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inhibitor discovered by Eisai, in combination with Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada)’s KEYTRUDA (generic name: pembrolizumab) has been […]
TOKYO and KENILWORTH, N.J., Feb 25, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of LENVIMA, the orally available multiple receptor tyrosine […]
Photo taken on Jan. 24, 2022 shows a COVID-19 testing site in Haidian District in Beijing, capital of China. (REN CHAO / XINHUA) The Chinese mainland reported 36 new locally-transmitted COVID-19 infections on Tuesday, up from 27 on Monday. Of the new local cases, 15 were reported in the province of Zhejiang, 12 in Tianjin, […]
TOKYO, Jan 31, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inhibitor discovered by Eisai, in combination with Merck & Co., Inc., Kenilworth, N.J., U.S.A.’s KEYTRUDA (generic name: pembrolizumab) has been approved in Taiwan for the first-line treatment of patients […]
TOKYO, Jan 17, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: LENVIMA, the orally available kinase inhibitor, “lenvatinib”) will be given at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (#GI22), […]
TOKYO, Dec 21, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that, effective January 1, 2022, Biogen will reduce the wholesale acquisition cost (WAC) of ADUHELM (aducanumab-avwa) 100 mg/mL injection for intravenous use in the United States by approximately 50%. For a patient of average weight (74 kg), the yearly cost […]
A 10-month-old patient with spinal muscular atrophy, or SMA, is taken to the hospital in Maoming, Guangdong province, in February. (PHOTO PROVIDED TO CHINA DAILY) Early this month, the world's first therapy to treat spinal muscular atrophy, or SMA, a rare genetic disorder that affects muscle control, was added to the National Reimbursement Drug List […]
This undated photo shows two employees working in a drug research and development laboratory in Dongguan, Guangdong province. (ZHAN YOUBING / FOR CHINA DAILY) BEIJING – The National Medical Products Administration has given emergency approval to the registration application of two COVID-19 medicines, BRII-196 and BRII-198. The two medicines are used in combination to treat […]
TOKYO, Nov 30, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the company will conduct a total of 42 poster presentations, including the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa) and in-house discovered and developed E2730, an investigational novel small compound for […]
